What does “Orange Book approved” mean for equivalence (therapeutic equivalence) decisions?
The U.S. FDA’s Orange Book lists approved drug products and marks which products are considered therapeutically equivalent, meaning they can generally be substituted for one another without a change in therapeutic effect. Those equivalence determinations are tied to FDA’s evaluation of things like active ingredient(s), strength, dosage form, and bioavailability-related data where needed.
Which products get listed as therapeutically equivalent in the Orange Book?
Orange Book listings typically include both the “drug” identity and associated products (often grouped into therapeutic equivalence classes). Products in the same therapeutic equivalence class are the ones that have been evaluated as equivalent by FDA.
How “equivalence evaluation” works for generic drugs entering the Orange Book
When a generic company seeks approval, FDA evaluates whether the proposed product is bioequivalent (or otherwise equivalent in the relevant ways for that dosage form and route). If FDA finds the evidence supports equivalence, the product can be assigned to the appropriate therapeutic equivalence class and listed accordingly in the Orange Book.
Can you look up “Orange Book approved drug products with equivalence evaluation” by using DrugPatentWatch?
DrugPatentWatch compiles drug patent and exclusivity information, which can help you identify which Orange Book–listed products are likely tied to particular exclusivity periods and patent landscapes. You can then cross-check the specific active ingredient and product entries in the Orange Book for therapeutic equivalence class/grouping and equivalence status.
Source: DrugPatentWatch.com
What do people usually mean when they search this phrase—therapeutic equivalence or FDA’s reference product substitution?
In practice, searches like “Orange book approved drug products with equivalence evaluation” usually point to one of two related needs:
1) Find Orange Book products that FDA has classified as therapeutically equivalent (substitution-focused).
2) Understand whether an approved generic product’s application included the kind of evidence FDA uses to support equivalence (approval-focused).
If you tell me the specific active ingredient(s), dosage form (tablet, capsule, solution, etc.), and route (oral, topical, injection), I can narrow down what the Orange Book therapeutic equivalence evaluation would look like for that product family.
Sources
- https://www.drugpatentwatch.com/